The patent ductus arteriosus (PDA) is the most commonly found cardiac condition in
neonates. While there have been several studies and thousands of publications on the topic …

Preterm infants are at increased risk for patent ductus arteriosus (PDA). Prolonged exposure
to PDA may be deleterious and has been associated with neonatal morbidity and mortality …

Patent ductus arteriosus (PDA) is a common clinical condition in preterm infants. Preterm
newborns with PDA are at greater risk for several morbidities, including higher rates of …

The Amplatzer Piccolo Occluder (or Amplatzer duct occluder II-additional sizes, ADO-II AS,
Abbott, Chicago, Illinois) was approved by the US Food and Drug Administration on January …

What is new for patent ductus arteriosus management in prema... : Current Opinion in
Pediatrics What is new for patent ductus arteriosus management in premature infants in …

Objective This article aims to determine the incidence of short-term complications of surgical
patent ductus arteriosus (PDA) ligations, the factors associated with those complications …

In preterm newborns with extremely low birth weights, patent ductus arteriosus (PDA), which
is defined as a remnant connection between the aorta and pulmonary artery after 72 hours …

Invasive interventions have been conducted in preterm infants with significant patent ductus
arteriosus (PDA) when medical treatment has failed, and methods of invasive intervention …

Objective: To characterize the number and methods of closure of Persistent Ductus
Arteriosus (PDA) over a span of 16 years in a third level maternity hospital. Methods …

Persistent arterial duct, also known as patent ductus arteriosus (PDA), is a common form of
congenital heart disease. The clinical implications and management of a PDA varies quite …